Global /Canada /Healthcare /Biotechnology /MOSS

Moss Genomics Inc.

MOSS

• CSE: MOSS • Delayed

0.0300CAD 0%

0.0215 USD

As of 7 June 2026, Moss Genomics Inc. has a market cap of $1.36M USD, ranking #47978 globally and #2591 in Canada. It ranks #4257 in the Healthcare sector, and #831 in the Biotechnology industry.

Global Rank

47978

Country Rank

2591

Sector Rank

4257

Industry Rank

831

Key Stats

Market Cap

$1.36MUSD

1.9M CAD

Company Profile

Country (HQ)

Canada

Sector

Healthcare

Industry

Biotechnology

CEO

Chengqi Liu open_in_new

Founded

2018

Website

mossgenomics.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	0%	-25%	500%	-63%	-50%	-87%	-86%	-70%

News

Markets

Exchange	Ticker	Price	Quotes
Canadian Securities Exchange (CSE) MIC: XCNQ PRIMARY	MOSS Moss Genomics Inc ISIN: CA61965T1012 TV: TradingView: CSE: MOSS SA: Stock Analysis: CSE: MOSS YF: Yahoo Finance: MOSS.CN GF: Google Finance: CNSX: MOSS BA: Barron's: MOSS MS: Morningstar: XCNQ: MOSS	0.0300 CAD	TV: TradingView: CSE: MOSS SA: Stock Analysis: CSE: MOSS YF: Yahoo Finance: MOSS.CN GF: Google Finance: CNSX: MOSS BA: Barron's: MOSS MS: Morningstar: XCNQ: MOSS
Cboe Canada (NEO) MIC: NEOE	MOSS Moss Genomics Inc ISIN: CA61965T1012 TV: TradingView: NEO: MOSS SA: Stock Analysis: NEO: MOSS YF: Yahoo Finance: MOSS.NE GF: Google Finance: NEO: MOSS BA: Barron's: MOSS MS: Morningstar: NEOE: MOSS	0.0700 CAD	TV: TradingView: NEO: MOSS SA: Stock Analysis: NEO: MOSS YF: Yahoo Finance: MOSS.NE GF: Google Finance: NEO: MOSS BA: Barron's: MOSS MS: Morningstar: NEOE: MOSS

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Moss Genomics Inc.

Moss Genomics Inc. is a biotechnology company focused on genomics and microbiome research to develop advanced genetic insights and solutions in Canada. It offers encrypted vault, genetic insights, and monetize your data; and vault hosting, pay per genome, and proof of personhood. The company was formerly known as Nou Camp Capital Corp. and changed its name to Moss Genomics Inc. in July 2021. Moss Genomics Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada.

Similar Companies

Industry: Biotechnology (Canada)

Name	Market Cap (USD) diff.	PE	Country
Aurinia Pharmaceuticals Inc. NASDAQ: AUPH	$1.99B 145K%	7.4	Canada
AbCellera Biologics Inc. NASDAQ: ABCL	$1.16B 85K%	-	Canada
Eupraxia Pharmaceuticals Inc. TSX: EPRX	$430.76M 600.89M CAD 31K%	-	Canada
NervGen Pharma Corp. TSXV: NGEN	$294.06M 410.19M CAD 21K%	-	Canada
Cybin Inc. NEO: CYBN	$253.15M 353.13M CAD 18K%	-	Canada
Cardiol Therapeutics Inc. TSX: CRDL	$149.17M 208.08M CAD 11K%	-	Canada

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 13M%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 12M%	19.0	United States
argenx SE EBR: ARGX	$48.08B 41.39B EUR 4M%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.48B 68.19T KRW 3M%	35.5	South Korea
CSL Ltd. ASX: CSL	$43.01B 60.27B AUD 3M%	29.3	Australia
Lonza Group AG SIX: LONN	$42.72B 33.71B CHF 3M%	37.2	Switzerland

chevron_leftBack